News-Details

Clinical benefits alone do not guarantee successful market access in Germany – Why?

In order to successfully enter the German market, it is necessary to be familiar with the relevant framework conditions and to correctly assess the role of the various stakeholders.

Medical innovations are only successful if they make a relevant contribution to patient care. They must close gaps in care, improve treatment outcomes or make procedures more efficient.

These criteria are crucial for doctors, because new technologies without clinical benefits will not be used.

In the German healthcare market, however, this clinical acceptance does not mark the end, but only the beginning of market access.

Service providers operate in a highly regulated system, while at the same time acting as economically independent players. In order for innovative services to be provided on a long-term basis, they have to be eligible for reimbursement and fit into existing structures.

Sustainable and successful market access is achieved when medical benefits are systematically combined with economic, regulatory and strategic expertise, rather than being based solely on value. Another decisive factor is how this is translated into the logic of the German healthcare system and where the relevant decisions are actually made.

Those who know these rules and apply them consistently lay the foundation for economically viable and long-term market penetration.

Would you like to ensure that your innovation gains access to the German market in a realistic, structured and rule-based manner?

Feel free to arrange a non-binding initial consultation with us.

Author: Healthcare Heads GmbH

Phone: +49 431 800 1470

E-Mail: info@healthcareheads.com